Historic Real-World Outcomes and Future Benchmarks for Patients with Diffuse Large B-Cell Lymphoma Receiving First- and Second-Line Therapy in Austria – a Large Single-Center ExperienceMichael Leisch, Thomas Melchardt, Dominik Kiem et al.|Technology in Cancer Research & Treatment|2026Cited by 0